The Great Healthcare Reversal Looms as Hospitals Lose Their Golden

Hospitals have been the easiest profitable trade in healthcare, but that streak is starting to crack. For the past five years, patients kept coming, procedures piled up, and operators like HCA HealthcareHCA

and Tenet HealthcareTHC

printed money. But that engine is slowing, and 2026 could be the year hospitals face a reckoning from new healthcare policies.

Brace for impact: Federal Medicaid funding could be cut by nearly $1T over the next decade — a shift that could push millions off coverage and hammer hospital reimbursements. Enhanced Affordable Care Act subsidies expired at the end of 2025, threatening to reverse coverage gains and weaken hospitals’ payer mix. The Trump administration is also weighing Medicare outpatient payment changes that could slice $11B from hospital revenue, including lower chemo reimbursements. That’s not the only thing putting stress on the volume-driven hospital model:

• Unemployment has risen from ~4% in early 2025 to 4.4% recently, adding strain as credit card, auto loan, and mortgage delinquencies climb.
• Over 300 rural hospitals face closure risk, while safety-net providers fight efforts to roll back 340B drug discount protections.

Reversal of Fortunes

The Wall Street Journal notes hospital stocks have dominated since 2020, while big insurers barely moved. That gap looks set to narrow as fundamentals shift, and Fitch says hospitals have this year to shore up balance sheets, invest in AI tools, and explore M&A before the toughest pressure hits in 2027. As Fitch’s Kevin Holloran put it, operators are already planning for the “worst-case scenario” and figuring out what they can do now to soften the blow.

• Government program margins across Medicare Advantage, Medicaid, and Marketplace plans are down 50%+, setting up a potential rebound as competition thins and rates rise.
• As Medicare Advantage rates jump 5%+ for 2026, insurers like UnitedHealthUNH
  and CenteneCNC
  could finally get some long-overdue breathing room.

The bitter pill: Alignment HealthcareALHC

is a smaller way to play a Medicare rebound, with Leerink’s Whit Mayo flagging its tech-driven care model and its track record of controlling costs even in a shaky Medicare Advantage market. However, hospitals face a different squeeze — stricter insurer pre-authorization rules are driving up supply and administrative costs, raising the risk of unpaid bills and higher bad debt. As Raymond James analyst Chris Meekins put it, if things break the wrong way, hospitals could face a “tornado of trouble.”